Migraine – Treatment

Go back

Migraine is far more than just a bad headache. It’s a complex neurological condition that can cause hours or even days of debilitating symptoms, including severe head pain, nausea, sensitivity to light and sound, and visual disturbances. While there is no cure for migraine, treatment options have advanced significantly in recent years, offering hope for better symptom control and improved quality of life through both established therapies and innovative approaches being tested in clinical trials.

How Modern Medicine Approaches Migraine Management

When someone experiences migraine, the treatment goals focus on several important areas. The first priority is to reduce the pain and other symptoms during an attack so the person can return to their normal activities as quickly as possible. The second goal involves preventing future attacks or at least making them less frequent and less severe. Treatment also aims to improve overall quality of life, helping people maintain their work, relationships, and daily responsibilities despite living with this chronic condition.[1]

The approach to treating migraine depends heavily on individual circumstances. A doctor will consider how often attacks occur, how severe they are, which symptoms are most troublesome, and how much the condition interferes with daily life. Some people experience only occasional migraines that respond well to simple pain relievers, while others have frequent, disabling attacks that require more comprehensive treatment strategies. The presence of other health conditions, such as heart disease or depression, also influences which treatments are safe and appropriate for each person.[2]

Modern migraine treatment falls into two main categories. Acute treatment (also called rescue or abortive treatment) aims to stop a migraine attack that has already started. Preventive treatment (also called prophylactic treatment) involves taking medication regularly, even when feeling well, to reduce how often attacks happen and how severe they are. Many people benefit from a combination of both approaches, along with lifestyle adjustments that help avoid known triggers.[3]

Medical societies and expert groups have developed clinical guidelines to help doctors choose the most effective treatments based on scientific evidence. These guidelines are regularly updated as new research emerges and new medications become available. In recent years, the field has seen exciting developments, including the first drugs designed specifically for migraine rather than borrowed from other conditions. Additionally, clinical trials continue to explore innovative therapies that may offer new options for people who haven’t found relief with existing treatments.[6]

Standard Treatment Approaches

Acute Treatment for Migraine Attacks

When a migraine attack begins, the goal is to treat it as quickly as possible. Taking medication early in an attack, ideally within the first hour of symptoms, tends to produce better results than waiting until the pain becomes severe. For mild to moderate migraines, over-the-counter pain relievers are often the first choice. These include common medications like ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation, and acetaminophen (also known as paracetamol), which relieves pain through a different mechanism. Some people find that aspirin also works well for their attacks.[4]

These simple pain relievers work by blocking chemicals in the body that cause pain and inflammation. They are widely available, relatively inexpensive, and have been used safely by millions of people. However, they may not be strong enough for moderate to severe attacks, and using them too frequently can actually make headaches worse over time—a problem called medication overuse headache or rebound headache.[8]

For more severe migraines, doctors often prescribe medications called triptans, which are specifically designed to treat migraine. These drugs work differently from simple pain relievers. They target serotonin receptors in the brain, causing blood vessels that have expanded during a migraine to narrow back to normal size, and they also block pain pathways in the nervous system. Several different triptans are available, including sumatriptan, rizatriptan, and zolmitriptan, each with slightly different properties.[10]

Triptans come in various forms to suit different needs. Some people prefer tablets that they can swallow with water. Others benefit from tablets that dissolve under the tongue or nasal sprays that work faster than pills. For people experiencing severe nausea and vomiting during attacks, injections that deliver medication directly into the muscle or under the skin can be particularly helpful because they don’t rely on the digestive system to work. The choice of triptan and delivery method should be individualized based on how quickly relief is needed, whether nausea is a problem, and how each person responds to different options.[11]

Triptans are generally safe and effective, but they’re not suitable for everyone. People with certain cardiovascular conditions, including uncontrolled high blood pressure, previous heart attack, or stroke, may not be able to use them safely because these medications can temporarily narrow blood vessels throughout the body, not just in the head. Common side effects include tingling sensations, feelings of warmth or flushing, tightness in the chest or throat, dizziness, and drowsiness. These effects are usually mild and temporary.[10]

Another class of medications used for acute migraine treatment is ergot alkaloids, such as dihydroergotamine. Like triptans, these drugs cause blood vessels to narrow and have effects on serotonin receptors. However, they are generally considered second-line treatments today because they tend to cause more side effects, including nausea and vomiting. They are most commonly used in hospital or clinic settings for people with severe, prolonged attacks that haven’t responded to other treatments.[9]

Anti-nausea medications, also called antiemetics, play an important role in migraine treatment even though they don’t directly relieve headache pain. Many people experience severe nausea and vomiting during migraine attacks, which can prevent them from keeping down oral medications and adds significantly to their distress. Medications like metoclopramide and prochlorperazine not only reduce nausea but may also have some pain-relieving properties. They work by blocking dopamine receptors in the brain. These medications are sometimes given alone for milder attacks or combined with pain relievers for more severe episodes.[8]

⚠️ Important
Using pain medications too frequently can actually make migraines worse. If you find yourself taking acute migraine medication more than two or three days per week on a regular basis, this could lead to medication overuse headache. In this situation, the medication itself becomes part of the problem, causing more frequent headaches. Talk to your doctor if you’re using acute treatments very often—this usually signals a need for preventive therapy.

Preventive Treatment

When someone experiences frequent migraine attacks—generally defined as four or more per month—or when attacks are so severe that they significantly disrupt life despite acute treatment, doctors often recommend preventive medication. The goal is not to cure migraine but to reduce how often attacks occur, make them less severe when they do happen, and improve response to acute treatment. Preventive therapy requires patience because these medications must be taken daily, whether or not a headache is present, and it often takes several weeks to months to see the full benefit.[6]

Many medications used for migraine prevention were originally developed for other conditions but were found to help reduce migraine frequency. Beta-blockers, such as propranolol and metoprolol, were designed to treat high blood pressure and heart conditions. They work by blocking the effects of stress hormones on the heart and blood vessels. While we don’t fully understand why they help prevent migraines, they are among the most commonly prescribed preventive medications and have strong evidence supporting their effectiveness.[9]

Certain medications used to treat epilepsy, called anticonvulsants or antiepileptic drugs, also help prevent migraines. Topiramate and valproate (also known as valproic acid or divalproex sodium) are the most commonly used in this category. They work by stabilizing electrical activity in the brain and affecting several chemical messengers. These medications can be quite effective, but they often cause side effects. Topiramate may cause tingling in the hands and feet, changes in taste, weight loss, difficulty finding words, and cognitive slowing. Valproate can cause weight gain, hair loss, tremor, and is particularly important to avoid during pregnancy because it can cause serious birth defects.[9]

Some antidepressants are effective for migraine prevention, particularly older medications called tricyclic antidepressants. Amitriptyline is the most studied and commonly used medication in this group. It affects several brain chemicals, including serotonin and norepinephrine, and may help stabilize pain pathways. This can be particularly helpful for people who have both migraine and depression or anxiety, addressing both conditions with one medication. Common side effects include dry mouth, drowsiness, constipation, and weight gain. Because it causes drowsiness, it’s usually taken at bedtime.[9]

Preventive medications typically need to be taken for at least two to three months before you can fully judge whether they’re working. During this time, keeping a headache diary to track attack frequency and severity helps determine if the medication is helping. If one preventive medication doesn’t work or causes intolerable side effects, doctors often try a different one, as people respond differently to various options. The goal is usually to reduce migraine frequency by at least half, though complete elimination of attacks is often not realistic with traditional preventive medications.[9]

Botulinum Toxin Injections

For people with chronic migraine—defined as having headache on 15 or more days per month, with at least 8 days meeting migraine criteria—botulinum toxin type A (commonly known by the brand name Botox) offers another preventive option. This treatment involves multiple small injections into specific muscles of the head, neck, and shoulders. The procedure is performed in a doctor’s office every 12 weeks. While botulinum toxin is famous for cosmetic uses, its role in chronic migraine is distinctly medical and evidence-based.[11]

Botulinum toxin works by temporarily blocking the release of certain chemicals at nerve endings, which may interrupt pain pathways involved in chronic migraine. It takes time to work, with people typically seeing gradual improvement over two or three treatment cycles. The most common side effects are temporary neck pain, headache shortly after injection, and muscle weakness near the injection sites. This treatment is specifically approved for chronic migraine and is not typically used for people with less frequent episodic migraine.[11]

Treatment in Clinical Trials

CGRP-Targeted Therapies

One of the most exciting developments in migraine treatment involves medications that target a specific molecule called calcitonin gene-related peptide, or CGRP for short. Scientists discovered that during migraine attacks, levels of CGRP—a protein that causes blood vessels to expand and transmits pain signals—increase dramatically in the blood. This discovery led to the development of two types of CGRP-targeted medications: monoclonal antibodies that block CGRP or its receptor, and small molecule drugs called gepants that block the CGRP receptor.[11]

CGRP monoclonal antibodies are preventive treatments given by injection or intravenous infusion. These are large protein molecules designed to either bind directly to CGRP, preventing it from causing its effects, or to block the receptor where CGRP would normally attach. Several have been approved for migraine prevention after completing extensive clinical trials. These include erenumab, which blocks the CGRP receptor, and fremanezumab, galcanezumab, and eptinezumab, which bind to CGRP itself.[11]

What makes these medications particularly attractive is their tolerability profile. Because they are large molecules that don’t easily cross into the brain and are highly specific to their target, they cause fewer side effects than many traditional preventive medications. The most common side effects are reactions at the injection site, such as pain, redness, or itching. Some people experience constipation. Importantly, these medications don’t cause the cognitive side effects, weight changes, or drowsiness often seen with older preventive treatments. They are given monthly or quarterly, depending on the specific medication and dosing regimen chosen.[11]

Clinical trials have shown that CGRP monoclonal antibodies can reduce monthly migraine days by an average of about four to five days in people with chronic migraine and two to three days in those with episodic migraine. While this might not sound dramatic, for people who have tried multiple other preventive medications without success, this reduction can be life-changing. The medications typically start working faster than traditional preventives, with some people noticing improvement within the first week or two, though maximum benefit may take up to three months.[11]

Gepants are a newer class of CGRP receptor blockers that come in pill or nasal spray form rather than injections. Unlike the monoclonal antibodies, which are large molecules, gepants are small molecules that can be taken orally. Some gepants, such as rimegepant and atogepant, have been studied both for acute treatment of migraine attacks and for prevention. This dual use makes them particularly interesting—the same medication can be taken during an attack to stop it and also taken daily to prevent attacks.[11]

Another gepant, zavegepant, was developed as a nasal spray specifically for acute treatment. It received regulatory approval as the first and only CGRP receptor antagonist nasal spray for acute treatment of migraine. The nasal spray formulation offers an alternative for people who have difficulty swallowing pills during an attack or who experience severe nausea. Clinical trials showed that zavegepant nasal spray could provide pain relief within two hours for many patients, with some people experiencing freedom from their most bothersome symptom within an hour.[8]

Gepants generally have a favorable side effect profile. The most common side effects in clinical trials were nausea, indigestion, and fatigue, though these were typically mild. Because they affect a different pathway than triptans, gepants can be used by some people who cannot take triptans due to cardiovascular concerns, though this should always be discussed with a doctor. Ongoing research continues to explore optimal dosing, long-term safety, and which patients benefit most from these medications.[11]

Other Acute Treatment Being Studied

Clinical trials continue to explore additional acute treatment options. One area of research involves new formulations of existing medications that might work faster or more reliably. For example, researchers have studied different ways to deliver triptans and other acute medications to speed absorption and improve effectiveness, including patches, powders, and newer injection devices that are easier to use.[8]

Another acute treatment that has been studied is lasmiditan, which works on serotonin receptors but through a different mechanism than triptans. Unlike triptans, lasmiditan doesn’t cause blood vessels to narrow, which means it might be safer for people with cardiovascular disease who cannot use triptans. In Phase III clinical trials, lasmiditan showed effectiveness in treating moderate to severe migraine attacks, with many patients experiencing freedom from pain within two hours. The main side effects include dizziness, fatigue, and a sensation of pins and needles. Because it can cause dizziness and drowsiness, people taking lasmiditan should not drive or operate machinery for at least eight hours after taking it.[11]

Innovative Preventive Approaches

Beyond CGRP-targeted therapies, researchers are exploring other preventive approaches in clinical trials. Some studies are investigating whether medications that affect different brain chemicals or pathways might help reduce migraine frequency. Others are looking at combination therapies, testing whether using two different types of preventive medication together works better than either alone.[9]

Non-pharmaceutical approaches are also being studied. Neuromodulation devices represent a particularly interesting area of research. These devices use electrical or magnetic stimulation to alter nerve activity that may be involved in migraine. Some devices are applied to the head or neck and are designed for use during an attack, while others are used regularly for prevention. The advantage of these approaches is that they avoid medication side effects entirely. Several such devices have completed clinical trials and received regulatory approval in various countries, including the United States and Europe, for both acute and preventive treatment of migraine.[9]

Understanding Clinical Trial Phases

When reading about migraine treatments in clinical trials, it helps to understand what the different trial phases mean. Phase I trials are small studies, usually involving healthy volunteers or a small number of patients, that primarily test whether a new treatment is safe and help determine appropriate doses. These trials provide initial information about how the body processes the medication and what side effects might occur.[5]

Phase II trials involve more people with the condition being studied—in this case, migraine. These trials continue to assess safety but focus more on whether the treatment actually works. Researchers measure outcomes like reduction in migraine days, pain relief, and improvement in quality of life. Phase II trials help determine the optimal dose and identify which patients might benefit most.[5]

Phase III trials are large studies, often involving hundreds or thousands of patients across multiple locations. These trials compare the new treatment directly to the current standard of care or to placebo (an inactive treatment). They provide the strongest evidence about whether a new treatment is effective and safe enough to be approved by regulatory agencies. Many Phase III migraine trials now take place across multiple countries, including sites in Europe, the United States, and other regions, allowing people from diverse backgrounds to participate and help determine whether treatments work well across different populations.[5]

⚠️ Important
Participating in a clinical trial for migraine treatment can offer access to new therapies before they become widely available, along with close monitoring by specialized medical teams. However, trials also involve uncertainty—the treatment being tested may not work better than existing options, and there may be unknown side effects. If you’re interested in clinical trials, discuss the potential benefits and risks with your doctor, who can help you understand whether participation might be appropriate for your situation.

Most common treatment methods

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Include medications like ibuprofen and aspirin that reduce pain and inflammation
    • Often used as first-line treatment for mild to moderate migraine attacks
    • Work by blocking chemicals in the body that cause pain and inflammation
    • Available over-the-counter and relatively inexpensive
  • Acetaminophen
    • Common pain reliever also known as paracetamol
    • Works through a different mechanism than NSAIDs
    • Can be effective for mild to moderate migraine attacks
    • May be combined with other medications for enhanced effect
  • Triptans
    • Medications specifically designed to treat migraine attacks
    • Target serotonin receptors in the brain to narrow blood vessels and block pain pathways
    • Include drugs like sumatriptan, rizatriptan, and zolmitriptan
    • Available in various forms: tablets, nasal sprays, and injections
    • First-line treatment for moderate to severe migraines
  • Anti-Nausea Medications (Antiemetics)
    • Include medications like metoclopramide and prochlorperazine
    • Block dopamine receptors in the brain to reduce nausea and vomiting
    • May have some pain-relieving properties in addition to treating nausea
    • Often used in combination with pain relievers during migraine attacks
  • Beta-Blockers
    • Preventive medications originally developed for heart conditions and high blood pressure
    • Include drugs like propranolol and metoprolol
    • Taken daily to reduce frequency and severity of migraine attacks
    • Block the effects of stress hormones on the heart and blood vessels
  • Anticonvulsants
    • Medications originally designed to treat epilepsy, also effective for migraine prevention
    • Include topiramate and valproate (valproic acid)
    • Work by stabilizing electrical activity in the brain
    • Taken daily as preventive therapy for people with frequent migraines
  • Tricyclic Antidepressants
    • Older antidepressant medications, particularly amitriptyline
    • Affect brain chemicals including serotonin and norepinephrine
    • Used daily as preventive treatment, often taken at bedtime
    • Can be helpful for people with both migraine and depression or anxiety
  • Botulinum Toxin Injections
    • Specifically approved for chronic migraine (15 or more headache days per month)
    • Involves multiple small injections into head, neck, and shoulder muscles
    • Treatment repeated every 12 weeks in a doctor’s office
    • Blocks release of chemicals at nerve endings that may interrupt pain pathways
  • CGRP Monoclonal Antibodies
    • Newer preventive treatments that target calcitonin gene-related peptide (CGRP)
    • Include medications like erenumab, fremanezumab, galcanezumab, and eptinezumab
    • Given by injection or intravenous infusion monthly or quarterly
    • Designed specifically for migraine with fewer side effects than traditional preventives
    • Work by blocking CGRP or its receptor to prevent migraine attacks
  • Gepants
    • Newer class of medications that block the CGRP receptor
    • Include rimegepant, atogepant, and zavegepant
    • Available in pill or nasal spray form
    • Some can be used both for acute treatment during attacks and for prevention
    • Zavegepant is the first CGRP receptor antagonist approved as a nasal spray for acute treatment
  • Ergot Alkaloids
    • Include medications like dihydroergotamine
    • Cause blood vessels to narrow and affect serotonin receptors
    • Generally considered second-line treatments due to side effects
    • Most commonly used in hospital settings for severe, prolonged attacks
  • Lasmiditan
    • Newer acute treatment that works on serotonin receptors differently than triptans
    • Does not narrow blood vessels, potentially safer for people with cardiovascular concerns
    • Effective in treating moderate to severe migraine attacks in clinical trials
    • Can cause dizziness and drowsiness, requiring caution with activities like driving

Lifestyle Management and Non-Drug Approaches

While medications play a crucial role in migraine management, lifestyle modifications and non-pharmaceutical approaches form an essential part of comprehensive treatment. People with migraine have what researchers describe as a sensitive or hyperexcitable nervous system, which means their brains respond more strongly to various triggers and changes in routine. Maintaining consistency and stability in daily habits can help raise the threshold at which migraine attacks occur, potentially reducing their frequency.[14]

Sleep regularity is one of the most important factors. Getting too much or too little sleep can trigger migraine attacks in many people. The goal is to maintain a consistent sleep schedule, going to bed and waking up at roughly the same time each day, even on weekends. This predictability helps stabilize the nervous system. Creating good sleep conditions—a dark, quiet, cool room free from electronic device screens before bedtime—also supports better sleep quality.[12]

Regular meals matter too. Skipping meals or going too long without eating can cause blood sugar levels to drop, triggering a migraine in susceptible people. Eating at consistent times throughout the day and not skipping breakfast provides the brain with steady fuel. While specific foods are sometimes blamed for triggering migraines, the evidence suggests that fewer than 10 percent of people with migraine have true food triggers. Rather than following restrictive diets based on lists of supposedly triggering foods, it’s more helpful to follow a balanced, anti-inflammatory diet rich in fruits, vegetables, and unprocessed foods while staying well hydrated.[16]

Regular physical activity can help prevent migraine attacks, though for some people, intense sudden exercise can trigger an attack. The key is to build up gradually, starting with gentle activities like walking and slowly increasing intensity over time. Research shows that people who exercise for at least two and a half hours per week tend to have fewer migraine days. Morning walks, in particular, can provide energy for the day ahead, and outdoor exercise may be especially beneficial. Yoga has been studied in migraine and appears to offer benefits as an add-on therapy to medication.[16]

Stress management is crucial because stress is one of the most commonly reported migraine triggers. While it’s impossible to eliminate stress from life, learning techniques to manage stress responses can help. Methods such as biofeedback, where people learn to recognize and control certain body functions like muscle tension, have evidence supporting their effectiveness. Relaxation techniques, including deep breathing exercises and progressive muscle relaxation, can also be helpful. Some people benefit from cognitive behavioral therapy, which teaches ways to change thought patterns and behaviors that may contribute to stress and pain.[9]

Identifying and avoiding personal triggers is important, though it requires patience and careful observation. Keeping a headache diary that tracks potential triggers alongside migraine attacks can help identify patterns. Common triggers include hormonal changes related to menstrual cycles, certain environmental factors like weather changes or strong smells, lack of sleep, stress, and bright or flashing lights. However, triggers are highly individual—what affects one person may not affect another, so personal tracking is more useful than following generic lists of triggers.[4]

Some people find benefit from complementary approaches like acupuncture, where fine needles are inserted at specific points on the body. While the mechanism isn’t fully understood, some clinical studies suggest acupuncture may help prevent migraine attacks when used regularly. Certain supplements, including riboflavin (vitamin B2), magnesium, and coenzyme Q10, have shown some evidence of benefit in migraine prevention, though the effects are generally modest compared to prescription medications.[11]

Ongoing Clinical Trials on Migraine

  • A Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Hungary Italy Poland
  • Study of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Hungary Italy Poland Portugal +1
  • Study on Rimegepant and Capsaicin for Migraine in Lean and Obese Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Diclofenac Potassium and Rimegepant for Treating Migraine in Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +5
  • Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark Finland France Germany +4
  • Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark Finland Germany Italy +3
  • Study on Migraine: Effects of Fremanezumab on Brain Chemistry in Patients with and without Aura

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Romania +1
  • Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany Italy The Netherlands Norway +2

References

https://www.mayoclinic.org/diseases-conditions/migraine-headache/symptoms-causes/syc-20360201

https://my.clevelandclinic.org/health/diseases/5005-migraine-headaches

https://www.ninds.nih.gov/health-information/disorders/migraine

https://www.nhs.uk/conditions/migraine/

https://www.ncbi.nlm.nih.gov/books/NBK560787/

https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360207

https://my.clevelandclinic.org/health/diseases/5005-migraine-headaches

https://americanheadachesociety.org/resources/primary-care/acute-treatment-for-migraine

https://pmc.ncbi.nlm.nih.gov/articles/PMC4709728/

https://www.aafp.org/pubs/afp/issues/2018/0215/p243.html

https://migrainetrust.org/live-with-migraine/healthcare/treatments/

https://www.mayoclinic.org/diseases-conditions/migraine-headache/in-depth/migraines/art-20047242

https://migrainetrust.org/live-with-migraine/

https://americanheadachesociety.org/resources/primary-care/lifestyle-modification-for-migraine

https://www.massgeneralbrigham.org/en/about/newsroom/articles/managing-migraines

https://ghlf.org/migraine/wellness-tips-for-chronic-migraine/

FAQ

How long does it take for preventive migraine medication to work?

Most traditional preventive medications need to be taken for at least two to three months before you can fully judge their effectiveness. Some people notice improvement sooner, but maximum benefit often requires several months of consistent daily use. Newer CGRP monoclonal antibodies may work faster, with some people experiencing improvement within the first few weeks, though it can still take up to three months to see full benefits. Patience is essential with preventive treatment—stopping too early may mean missing out on help that would have come with more time.

Can I take acute migraine medication every day if I have frequent attacks?

No, taking acute migraine medication more than two to three days per week regularly can lead to medication overuse headache, where the medication itself starts causing more frequent headaches. If you’re using acute treatments this often, it’s a signal that you need preventive therapy. Talk to your doctor about starting a daily preventive medication to reduce the frequency of your attacks rather than continuing to rely heavily on acute treatments.

What’s the difference between migraine with aura and migraine without aura?

Migraine without aura, which accounts for about 75 percent of cases, involves recurrent headache attacks without warning signs beforehand. Migraine with aura includes warning symptoms that typically occur 5 to 60 minutes before the headache starts. Aura symptoms most commonly involve vision changes like seeing zigzag lines, flashing lights, or temporary blind spots, but can also include numbness, tingling, pins and needles sensations, or difficulty speaking. Some people experience both types at different times.

Why can’t people with certain heart conditions use triptans?

Triptans work partly by causing blood vessels to narrow, which helps reverse the blood vessel expansion that occurs during migraine. However, this narrowing effect doesn’t only happen in the head—it can also affect blood vessels throughout the body, including those supplying the heart. For people with cardiovascular disease, uncontrolled high blood pressure, or previous heart attack or stroke, this blood vessel narrowing could potentially trigger serious heart problems. That’s why doctors carefully screen patients before prescribing triptans and may choose alternative treatments like gepants or lasmiditan for people with cardiovascular concerns.

Are the newer CGRP medications better than older preventive treatments?

CGRP-targeted medications represent the first drugs designed specifically for migraine prevention, and they have some important advantages. They generally cause fewer side effects than traditional preventive medications—no weight gain, cognitive problems, or drowsiness—and they’re given by injection or infusion rather than daily pills. However, “better” depends on individual circumstances. Traditional preventive medications have decades of use and safety data, they work through different mechanisms that may be more effective for some people, and they’re generally less expensive. The best choice depends on your specific situation, other health conditions, previous treatment responses, and preferences.

🎯 Key takeaways

  • Migraine is a genetic neurological disease, not “just a headache,” and affects an estimated 12 percent of people, with women three times more likely to experience it than men
  • Treatment approaches divide into two main categories: acute treatments to stop attacks in progress and preventive treatments taken daily to reduce attack frequency and severity
  • Taking acute migraine medication early in an attack works better than waiting for severe pain, but using these medications too frequently (more than 2-3 days per week) can cause medication overuse headache
  • Traditional preventive medications like beta-blockers, anticonvulsants, and tricyclic antidepressants were all originally developed for other conditions but have proven effectiveness in reducing migraine frequency
  • Newer CGRP-targeted therapies represent the first medications designed specifically for migraine, offering effective prevention with fewer side effects like cognitive problems or weight changes
  • Gepants are innovative medications that can work both for acute treatment during an attack and as preventive therapy, with zavegepant becoming the first CGRP nasal spray approved for acute migraine
  • Botulinum toxin injections specifically help people with chronic migraine (15 or more headache days per month) through quarterly treatments in a doctor’s office
  • Clinical trials continue across multiple phases testing new treatments, with Phase III trials providing the strongest evidence before medications receive regulatory approval
  • Lifestyle modifications including consistent sleep schedules, regular meals, exercise, and stress management complement medication by stabilizing the hyperexcitable nervous system characteristic of migraine
  • Despite significant advances, there is still no cure for migraine, making ongoing research into new therapies crucial for improving outcomes for the millions of people affected by this disabling condition